Hospital Infection Prevention-CDC home care survey finds 16% infections
Hospital Infection Prevention-CDC home care survey finds 16% infections
But only 8% acquired via home care
Highlights of a survey of infections in home care conducted by the Centers for Disease Control and Prevention and the Missouri Alli ance for Home Care included findings summarized as follows:
During June 1-30, 1999, home care nurses in 73 Missouri home care agencies completed questionnaires on 5,148 patients. Of those patients, 793 (16%) were reported to have infections.
Of the infections, 8% were reported as home care-acquired, 16% as hospital-acquired, and the remainder as community-acquired (41%) or unknown (35%). Overall, 90% were treated with antimicrobials, including 4% treated with vancomycin.
The most common infection sites were the urinary tract (27%), respiratory tract (24%), skin/soft tissue (24%), surgical site (12%), or bloodstream (2%). Another 18% of infections occurred at other body sites (e.g., gastrointestinal tract, bone).
Invasive medical devices were present in 1,729 (34%) of surveyed patients. Of those, 21% had a urethral or suprapubic catheter; 17% a central venous catheter; 14% another device (e.g., wound drainage tube, tracheostomy or nephrostomy tube, or implanted device); 7% a gastrostomy tube; and 1% a mechanical ventilator. Use of a urethral or suprapubic catheter was associated with a higher risk of urinary tract infection (76/297 vs. 138/4,637). Use of a central catheter was associated with a higher risk of bloodstream infection (6/283 vs. 9/4,850). Venti lator use (1/10 vs. 186/4,951) was not associa ted with respiratory tract infection.
Reference
1. Manangan LP, Schantz M, Pearson MI, et al. Prevalence of infections among patients in home care. Abstract PM1-27. Presented at the Centers for Disease Control and Prevention 4th Decennial International Conference on Nosocomial and Healthcare-Associated Infection. Atlanta; March 5-9, 2000.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.